Article

Key Elements Affecting Biosimilar Uptake in the United States

Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

Related Videos
Related Content
NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies
April 1st 2025

NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Schizophrenia
April 1st 2025

Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment

Angie Oster, PharmD Cara Colodonato, PharmD
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
Herpes Zoster as an Early Indicator of HIV: Clinical Insights
March 31st 2025

Herpes Zoster as an Early Indicator of HIV: Clinical Insights

Emilia Welch, PharmD, MBA
X-ray image of liver -- Image credit: Sebastian Kaulitzki | stock.adobe.com
March 31st 2025

BEAM-302 Receives FDA IND Clearance for AATD, a Genetic Disorder Affecting the Liver and Lungs

Gillian McGovern, Associate Editor